The Effect of Grape Seed Extract Supplementation on Fasting Blood Sugar Status, Insulin Resistance and Lipid Profile in Women with Polycystic Ovary Syndrome

Not Applicable

Conditions: Polycystic Ovary Syndrome(PCOS).
Newborn light for gestational age, 2000-2499 grams
P05.08

Registration Number: IRCT20190122042458N1

Lead Sponsor: Ahvaz University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Complete

Sex: Female

Target Recruitment: 50

Inclusion Criteria

Age of Admission 25 to 60 Years
Body Mass Index Less than or Equal to 30
Diagnosis of Women with Polycystic Ovarian Syndrome Defined as Presence of 2 Characteristics of the Following 3 Characteristics: Oligoavulation or non Ovulation, Biochemical and / or Clinical Evidence of Hyperandrogenism, Features of Transvaginal Ultrasonography Representing More than 12 Immature Follicles Less than 10 mm Per Ovary

Exclusion Criteria

Unwillingness of Patients to Participate in the Study
Kidney Disease, Coronary Arteries, Acute and Chronic Pulmonary Inflammation, Short Stomach and Intestine Syndrome, Allergies
Pregnancy and Lactation
Traveling for More than 2 Weeks
Smokers
Use of Food Supplements
Anti-Inflammatory Drugs
Use of any Antioxidant Supplement in the Last 3 Months
Use of Immunosuppressive Drugs
Follow Certain Diets
Change the Diet or Decide to Lose Weight

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
HDL. Timepoint: 0-60. Method of measurement: Laboratory Kits.;LDL. Timepoint: 0-60. Method of measurement: Laboratory Kits.;T.G. Timepoint: 0-60. Method of measurement: Laboratory Kits.;FBS. Timepoint: 0-60. Method of measurement: Laboratory Kits.;Insulin resistance. Timepoint: 0-60. Method of measurement: Laboratory Kits.;Insulin. Timepoint: 0-60. Method of measurement: Laboratory Kits.

Secondary Outcome Measures